N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N~2~-methyl-N-(4-methylphenyl)glycinamide
Chemical Structure Depiction of
N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N~2~-methyl-N-(4-methylphenyl)glycinamide
N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N~2~-methyl-N-(4-methylphenyl)glycinamide
Compound characteristics
Compound ID: | K906-3278 |
Compound Name: | N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N~2~-methyl-N-(4-methylphenyl)glycinamide |
Molecular Weight: | 416.45 |
Molecular Formula: | C19 H20 N4 O5 S |
Smiles: | Cc1ccc(cc1)NC(CN(C)S(c1ccc2c(c1)C(NCC(N2)=O)=O)(=O)=O)=O |
Stereo: | ACHIRAL |
logP: | 1.9056 |
logD: | 1.3724 |
logSw: | -3.0732 |
Hydrogen bond acceptors count: | 11 |
Hydrogen bond donors count: | 3 |
Polar surface area: | 106.115 |
InChI Key: | ZRLVLCZPHWHZRV-UHFFFAOYSA-N |